Michael A. Liss

8.2k total citations
261 papers, 5.2k citations indexed

About

Michael A. Liss is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michael A. Liss has authored 261 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Pulmonary and Respiratory Medicine, 77 papers in Surgery and 62 papers in Molecular Biology. Recurrent topics in Michael A. Liss's work include Prostate Cancer Diagnosis and Treatment (79 papers), Prostate Cancer Treatment and Research (53 papers) and Renal cell carcinoma treatment (42 papers). Michael A. Liss is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (79 papers), Prostate Cancer Treatment and Research (53 papers) and Renal cell carcinoma treatment (42 papers). Michael A. Liss collaborates with scholars based in United States, Germany and Canada. Michael A. Liss's co-authors include Hans Wolf, Birgit Petersen, Elke Prohaska, Dharam Kaushik, Kathryn Osann, Kerrin Palazzi, Ralf Wagner, Richard J. Szabo, Christopher J. Kane and Ithaar Derweesh and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael A. Liss

243 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Liss United States	39	2.3k	1.9k	1.2k	787	647	261	5.2k
Theo M. de Reijke Netherlands	40	3.7k 1.6×	1.3k 0.7×	2.6k 2.1×	969 1.2×	347 0.5×	189	7.5k
Han Yong Choi South Korea	33	2.0k 0.9×	1.3k 0.7×	870 0.7×	562 0.7×	239 0.4×	160	3.8k
Robert K. Nam Canada	44	5.4k 2.3×	1.6k 0.8×	1.5k 1.2×	1.5k 1.9×	616 1.0×	165	8.7k
Daniel W. Chan United States	50	2.6k 1.1×	4.1k 2.1×	820 0.7×	1.1k 1.5×	586 0.9×	161	9.4k
Kim Pettersson Finland	58	3.6k 1.5×	3.4k 1.8×	877 0.7×	956 1.2×	522 0.8×	291	10.9k
William C. DeWolf United States	43	2.2k 1.0×	1.7k 0.9×	1.3k 1.1×	672 0.9×	233 0.4×	145	6.0k
Cary N. Robertson United States	42	3.1k 1.3×	1.8k 0.9×	1.3k 1.1×	2.3k 2.9×	287 0.4×	132	8.1k
Charles J. Rosser United States	46	1.6k 0.7×	2.4k 1.2×	2.0k 1.6×	1.7k 2.2×	470 0.7×	217	6.2k
Ganesh S. Palapattu United States	41	2.7k 1.1×	1.6k 0.8×	2.9k 2.4×	1.3k 1.6×	224 0.3×	185	6.5k
Alessandro Sciarra Italy	41	3.5k 1.5×	1.3k 0.7×	954 0.8×	775 1.0×	324 0.5×	250	6.6k

Countries citing papers authored by Michael A. Liss

Since Specialization

Citations

This map shows the geographic impact of Michael A. Liss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Liss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Liss more than expected).

Fields of papers citing papers by Michael A. Liss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Liss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Liss. The network helps show where Michael A. Liss may publish in the future.

Co-authorship network of co-authors of Michael A. Liss

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Liss. A scholar is included among the top collaborators of Michael A. Liss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Liss. Michael A. Liss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Salmasi, Amirali, et al.. (2026). Killing cancer takes guts: lessons learned from the manipulation of gut microbiome and immunotherapy for the future of urothelial carcinoma. OncoImmunology. 15(1). 2611458–2611458.

Leach, Robin J., et al.. (2026). Surgical operation duration as a predictor of venous thromboembolism risk after radical cystectomy. Urologic Oncology Seminars and Original Investigations. 110983–110983.

Liu, Shiqin, En‐Chi Hsu, Merve Aslan, et al.. (2025). Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis. Cancer Research. 85(23). 4632–4647.

Noyes, Sabrina L., Margaret Meagher, Richard K.K. Yuen, et al.. (2024). MP51-08 EXTERNAL VALIDATION OF RENSAFE: A TOOL TO PREDICT ACUTE KIDNEY INJURY AND CHRONIC KIDNEY DISEASE >3B POST PARTIAL OR RADICAL NEPHRECTOMY. The Journal of Urology. 211(5S).

Shen, Michelle, Fernando Jose Garcia-Marques, Shiqin Liu, et al.. (2024). Identification of a 5-gene signature panel for the prediction of prostate cancer progression. British Journal of Cancer. 131(11). 1748–1761. 1 indexed citations

Liss, Michael A., Achinto Saha, Atul Rathore, et al.. (2024). Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules. Journal of Traditional and Complementary Medicine. 14(5). 558–567. 8 indexed citations

Garza, Maryam Y., Michael A. Liss, Sunita Yadav, et al.. (2024). Comparing the Accuracy of Traditional vs. FHIR®-Based Extraction of Electronic Health Record Data for Two Clinical Trials. Studies in health technology and informatics. 316. 1368–1372. 1 indexed citations

Lorenzo, Guillermo, Michael A. Liss, Michael I. Miga, et al.. (2024). A Pilot Study on Patient-specific Computational Forecasting of Prostate Cancer Growth during Active Surveillance Using an Imaging-informed Biomechanistic Model. Cancer Research Communications. 4(3). 617–633. 6 indexed citations

Newcomb, Lisa F., Jeannette M. Schenk, Yingye Zheng, et al.. (2024). Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 331(24). 2084–2084. 22 indexed citations

10.

Wang, Hanzhang, Dharam Kaushik, Michael A. Liss, et al.. (2023). Impact of rural residence on the presentation, management and survival of patients with non-metastatic muscle-invasive bladder carcinoma. Investigative and Clinical Urology. 64(6). 561–561. 1 indexed citations

11.

Wang, Hanzhang, Ronald Rodríguez, Michael A. Liss, et al.. (2022). Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma. International Journal of Clinical Oncology. 27(6). 1068–1076. 15 indexed citations

12.

Wang, Hanzhang, Shenghui Wu, Michael A. Liss, et al.. (2022). Histological variants of non–muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy. Urologic Oncology Seminars and Original Investigations. 40(6). 275.e1–275.e10. 9 indexed citations

13.

Ramamurthy, Chethan, Martin Goros, Jonathan Gelfond, et al.. (2022). Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer. Clinical Genitourinary Cancer. 20(3). 237–243. 4 indexed citations

14.

Bohan, Phillip M. Kemp, Robert C. Chick, Timothy J. Vreeland, et al.. (2021). Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent Progression. Cancer Prevention Research. 14(5). 551–562. 9 indexed citations

15.

Osmulski, Paweł A., Meizhen Chen, Chun-Lin Lin, et al.. (2021). Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer. Cancer Research. 81(15). 4110–4123. 38 indexed citations

16.

Zhu, Kehao, Yingye Zheng, Lisa F. Newcomb, et al.. (2021). Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer. 128(2). 269–274. 5 indexed citations

17.

Wang, Hanzhang, Dharam Kaushik, Michael A. Liss, et al.. (2020). Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only. Urologic Oncology Seminars and Original Investigations. 38(4). 231–239. 4 indexed citations

18.

Chiocchini, Claudia, et al.. (2020). From Electronic Sequence to Purified Protein Using Automated Gene Synthesis and In Vitro Transcription/Translation. ACS Synthetic Biology. 9(7). 1714–1724. 4 indexed citations

19.

Horning, Aaron M., Yao Wang, Anna D. Louie, et al.. (2017). Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle–Related Transcription and Attenuated Androgen Response. Cancer Research. 78(4). 853–864. 81 indexed citations

20.

Patel, Nishant, Jason Woo, Michael A. Liss, et al.. (2016). Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.. PubMed. 23(2). 8227–33. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact